CDC Allows Novavax Monovalent COVID-19 Boosters for Adults Ages 18 and Older
Today, CDC’s Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo allowing Novavax monovalent COVID-19 boosters for adults.
WordPress database error: [Table 'acdlpb3_wp339.wpe5_wpsecure_login' doesn't exist]SHOW COLUMNS FROM wpe5_wpsecure_login LIKE "country"
WordPress database error: [Table 'acdlpb3_wp339.wpe5_wpsecure_login' doesn't exist]ALTER TABLE wpe5_wpsecure_login ADD country VARCHAR(150)
WordPress database error: [Table 'acdlpb3_wp339.wpe5_wpsecure_login' doesn't exist]ALTER TABLE wpe5_wpsecure_login ADD city VARCHAR(100)
Today, CDC’s Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo allowing Novavax monovalent COVID-19 boosters for adults.
Today, CDC’s Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo allowing Novavax monovalent COVID-19 boosters for adults.
Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo that Novavax’s COVID-19 vaccine be used as another primary series option for adolescents ages 12 through 17.